Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinomaHeather R Ferguson, Christopher P Wild, Lesley A Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control studyHeather R Ferguson, Christopher P Wild, Lesley A Anderson, et al.
Cancer Causes & Control : CCC|October 8, 2008
Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinomaHelen G Mulholland, Marie M Cantwell, Lesley A Anderson, et al.
The American Journal of Gastroenterology|August 31, 2016
Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's EsophagusAaron P Thrift, Lesley A Anderson, Liam J Murray, et al.
Annals of Clinical and Translational Neurology|August 13, 2019
Benign tumors in myotonic dystrophy type I target disease-related cancer sitesRotana Alsaggaf, Diane Marie M St George, Min Zhan, et al.
Plos One|January 18, 2018
Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR StudyJessica L Petrick, Roni T Falk, Paula L Hyland, et al.
British Journal of Cancer|April 8, 2025
Infectious agents and progression from Barrett's oesophagus to oesophageal adenocarcinoma: a nested case-control studyTalita H A de Oliveira, Lesley A Anderson, Stephanie G Craig, et al.
Gastroenterology|September 24, 2018
Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk FactorsAndrew T Kunzmann, Marisa Cañadas Garre, Aaron P Thrift, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2019
Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern IrelandStephanie G Craig, Lesley A Anderson, Michael Moran, et al.
British Journal of Cancer|March 21, 2019
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approachStephanie G Craig, Lesley A Anderson, Andrew G Schache, et al.
Pageof 10